294 related articles for article (PubMed ID: 22393289)
1. Nanobubbles for enhanced ultrasound imaging of tumors.
Yin T; Wang P; Zheng R; Zheng B; Cheng D; Zhang X; Shuai X
Int J Nanomedicine; 2012; 7():895-904. PubMed ID: 22393289
[TBL] [Abstract][Full Text] [Related]
2. Production and characterization of a novel long-acting Herceptin-targeted nanobubble contrast agent specific for Her-2-positive breast cancers.
Jiang Q; Hao S; Xiao X; Yao J; Ou B; Zhao Z; Liu F; Pan X; Luo B; Zhi H
Breast Cancer; 2016 May; 23(3):445-55. PubMed ID: 25691133
[TBL] [Abstract][Full Text] [Related]
3. Construction of Nucleolin-Targeted Lipid Nanobubbles and Contrast-Enhanced Ultrasound Molecular Imaging in Triple-Negative Breast Cancer.
Fang K; Wang L; Huang H; Lan M; Shen D; Dong S; Guo Y
Pharm Res; 2020 Jul; 37(7):145. PubMed ID: 32666304
[TBL] [Abstract][Full Text] [Related]
4. Preparation Of Nanobubbles Modified With A Small-Molecule CXCR4 Antagonist For Targeted Drug Delivery To Tumors And Enhanced Ultrasound Molecular Imaging.
Peng Y; Zhu L; Wang L; Liu Y; Fang K; Lan M; Shen D; Liu D; Yu Z; Guo Y
Int J Nanomedicine; 2019; 14():9139-9157. PubMed ID: 32063704
[TBL] [Abstract][Full Text] [Related]
5. Targeted Nanobubbles Carrying Indocyanine Green for Ultrasound, Photoacoustic and Fluorescence Imaging of Prostate Cancer.
Wang Y; Lan M; Shen D; Fang K; Zhu L; Liu Y; Hao L; Li P
Int J Nanomedicine; 2020; 15():4289-4309. PubMed ID: 32606678
[TBL] [Abstract][Full Text] [Related]
6. Novel lactoferrin-conjugated amphiphilic poly(aminoethyl ethylene phosphate)/poly(L-lactide) copolymer nanobubbles for tumor-targeting ultrasonic imaging.
Luo B; Liang H; Zhang S; Qin X; Liu X; Liu W; Zeng F; Wu Y; Yang X
Int J Nanomedicine; 2015; 10():5805-17. PubMed ID: 26396514
[TBL] [Abstract][Full Text] [Related]
7. Novel DiR and SPIO nanoparticles embedded PEG-PLGA nanobubbles as a multimodalimaging contrast agent.
Luo B; Zhang H; Liu X; Rao R; Wu Y; Liu W
Biomed Mater Eng; 2015; 26 Suppl 1():S911-6. PubMed ID: 26406092
[TBL] [Abstract][Full Text] [Related]
8. FA-NBs-IR780: Novel multifunctional nanobubbles as molecule-targeted ultrasound contrast agents for accurate diagnosis and photothermal therapy of cancer.
Shen Y; Lv W; Yang H; Cai W; Zhao P; Zhang L; Zhang J; Yuan L; Duan Y
Cancer Lett; 2019 Jul; 455():14-25. PubMed ID: 31018151
[TBL] [Abstract][Full Text] [Related]
9. Optimized Anti-Prostate-Specific Membrane Antigen Single-Chain Variable Fragment-Loaded Nanobubbles as a Novel Targeted Ultrasound Contrast Agent for the Diagnosis of Prostate Cancer.
Ding Y; Cao Q; Qian S; Chen X; Xu Y; Chen J; Shen H
J Ultrasound Med; 2020 Apr; 39(4):761-773. PubMed ID: 31702068
[TBL] [Abstract][Full Text] [Related]
10. Paclitaxel-loaded and A10-3.2 aptamer-targeted poly(lactide-
Wu M; Wang Y; Wang Y; Zhang M; Luo Y; Tang J; Wang Z; Wang D; Hao L; Wang Z
Int J Nanomedicine; 2017; 12():5313-5330. PubMed ID: 28794625
[TBL] [Abstract][Full Text] [Related]
11. Methotrexate-loaded PLGA nanobubbles for ultrasound imaging and Synergistic Targeted therapy of residual tumor during HIFU ablation.
Zhang X; Zheng Y; Wang Z; Huang S; Chen Y; Jiang W; Zhang H; Ding M; Li Q; Xiao X; Luo X; Wang Z; Qi H
Biomaterials; 2014 Jun; 35(19):5148-61. PubMed ID: 24680663
[TBL] [Abstract][Full Text] [Related]
12. Construction of a Tumor-Targeting Nanobubble with Multiple Scattering Interfaces and its Enhancement of Ultrasound Imaging.
Ma Z; Zhang Y; Zhu Y; Cui M; Liu Y; Duan YY; Fan L; Zhang L
Int J Nanomedicine; 2024; 19():4651-4665. PubMed ID: 38799698
[TBL] [Abstract][Full Text] [Related]
13. Multicolor nanobubbles for FRET/ultrasound dual-modal contrast imaging.
Zhang X; Liu R; Dai Z
Nanoscale; 2018 Nov; 10(43):20347-20353. PubMed ID: 30375631
[TBL] [Abstract][Full Text] [Related]
14. Multifunctional nanoparticles for combining ultrasonic tumor imaging and targeted chemotherapy.
Rapoport N; Gao Z; Kennedy A
J Natl Cancer Inst; 2007 Jul; 99(14):1095-106. PubMed ID: 17623798
[TBL] [Abstract][Full Text] [Related]
15. Effect of Bubble Concentration on the in Vitro and in Vivo Performance of Highly Stable Lipid Shell-Stabilized Micro- and Nanoscale Ultrasound Contrast Agents.
Abenojar EC; Nittayacharn P; de Leon AC; Perera R; Wang Y; Bederman I; Exner AA
Langmuir; 2019 Aug; 35(31):10192-10202. PubMed ID: 30913884
[TBL] [Abstract][Full Text] [Related]
16. Improving ovarian cancer imaging with LHRH-NBs: an experimental study.
Li W; Zhang L; Zhu Y; Zhang J; Shen L; Huang S; Fang S
Arch Gynecol Obstet; 2016 Sep; 294(3):631-8. PubMed ID: 27075493
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic modeling of PSMA-targeted nanobubbles for quantification of extravasation and binding in mice models of prostate cancer.
Chen C; Perera R; Kolios MC; Wijkstra H; Mischi M; Exner AA; Turco S
Med Phys; 2022 Oct; 49(10):6547-6559. PubMed ID: 36049109
[TBL] [Abstract][Full Text] [Related]
18. The therapeutic effect in gliomas of nanobubbles carrying siRNA combined with ultrasound-targeted destruction.
Cai W; Lv W; Feng Y; Yang H; Zhang Y; Yang G; Duan Y; Wang J
Int J Nanomedicine; 2018; 13():6791-6807. PubMed ID: 30425489
[TBL] [Abstract][Full Text] [Related]
19. Combined legumain- and integrin-targeted nanobubbles for molecular ultrasound imaging of breast cancer.
Mi X; Guo X; Du H; Han M; Liu H; Luo Y; Wang D; Xiang R; Yue S; Zhang Y; Tan X
Nanomedicine; 2022 Jun; 42():102533. PubMed ID: 35150904
[TBL] [Abstract][Full Text] [Related]
20. Cyanine 5.5 conjugated nanobubbles as a tumor selective contrast agent for dual ultrasound-fluorescence imaging in a mouse model.
Mai L; Yao A; Li J; Wei Q; Yuchi M; He X; Ding M; Zhou Q
PLoS One; 2013; 8(4):e61224. PubMed ID: 23637799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
